|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Mabvax Therapeutics Holdings Inc (MBVX) |
|
|
$0.02 0.00 (0.00%) as of 4:30 Thu 3/12
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
8,960,000 |
| Market
Cap: |
206.08(K) |
| Last
Volume: |
52,147 |
Avg
Vol: |
52,003 |
| 52
Week Range: |
$0.023 - $0.023 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Livingston Philip O. |
Chief Science Officer |
• • – |
2015-04-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,000,000 |
1,307,396 |
|
- |
|
| Ravetch Jeffrey V. |
Director |
– • – |
2015-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
131,500 |
131,500 |
|
- |
|
| Varvaro Thomas C |
|
– • – |
2015-04-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,250 |
|
- |
|
| Cohen Kenneth M |
Director |
– • – |
2014-12-17 |
4 |
B |
$1.80 |
$4,500 |
I/I |
2,500 |
17,616 |
2.1 |
- |
|
| Maffuid Paul W |
Vice President |
• – – |
2014-12-16 |
5 |
B |
$2.85 |
$14,250 |
D/D |
5,000 |
5,000 |
|
- |
|
| Cohen Kenneth M |
Director |
– • – |
2014-12-16 |
4 |
B |
$2.41 |
$9,640 |
I/I |
4,000 |
15,116 |
2.1 |
- |
|
| Hoffman Robert |
Director |
– • – |
2014-12-16 |
4 |
B |
$2.40 |
$24,000 |
D/D |
10,000 |
21,116 |
2.39 |
- |
|
| Hanson Gregory P |
Chief Financial Officer |
• – – |
2014-12-16 |
4 |
B |
$2.50 |
$7,500 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
| Antonopoulos Jim J. |
former director |
– – – |
2014-09-12 |
4 |
S |
$6.00 |
$71,352 |
D/D |
(11,892) |
21,258 |
|
- |
|
| Antonopoulos Jim J. |
former director |
– – – |
2014-09-12 |
4 |
OE |
$3.62 |
$120,003 |
D/D |
33,150 |
33,150 |
|
- |
|
| Wetherell David S |
10% Owner |
– – • |
2014-07-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,162,258 |
|
- |
|
| Scholz Wolfgang W. |
VP of Antibody DiscoveryOffice |
• – – |
2014-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
400,192 |
|
- |
|
| Hansen John David |
President and CEOOfficer |
• • – |
2014-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
533,589 |
|
- |
|
| Livingston Philip O. |
Chief Science OfficerOfficer |
• • – |
2014-07-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,563,123 |
|
- |
|
| Livingston Philip O. |
Chief Science OfficerOfficer |
• • – |
2014-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
881,181 |
|
- |
|
115 Records found
|
|
Page 5 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
